CATALYST BIOSCIENCES, INC. Purchase Agreements
9 Contracts & Agreements
- Securities Purchase Agreement, dated October 27, 2023, by and between Catalyst and GNI USA (Filed With SEC on October 30, 2023)
- Agreement and Amendment to Asset Purchase Agreement, dated as of March 29, 2023, by and among Catalyst, GNI Group and GNI HK (Filed With SEC on March 30, 2023)
- Asset Purchase Agreement dated as of February 27, 2023 by and between Catalyst Biosciences, Inc. and GC Biopharma Corp (Filed With SEC on March 2, 2023)
- Asset Purchase Agreement, dated December 26, 2022, by and among Catalyst Biosciences, Inc., GNI Group Ltd., and GNI Hong Kong Limited (Filed With SEC on December 27, 2022)
- ASSET PURCHASE AND TRADEMARK ASSIGNMENT AGREEMENT (Filed With SEC on March 14, 2008)
- ASSET PURCHASE AND TRADEMARK ASSIGNMENT AGREEMENT (Filed With SEC on January 17, 2006)
- ASSET PURCHASE AGREEMENT (Filed With SEC on January 17, 2006)
- ASSET PURCHASE AND TRADEMARK ASSIGNMENT AGREEMENT (Filed With SEC on May 14, 2004)
- ASSET PURCHASE AGREEMENT (Filed With SEC on May 14, 2004)
